Timothy P. Walbert, Chairman, President and CEO at Horizon Therapeutics Public Ltd Co (HZNP), sold 122,100 shares at $90.41 ($11.1M) on 2022-02-28, disclosed to the SEC on 2022-03-01.
Seasonal sale ($11.1M) by Chairman, President and CEO — this insider has traded HZNP in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.51 | 25,000 | $2.3M | 20.7% |
| 2 | $90.41 | 26,892 | $2.4M | 21.8% |
| 3 | $90.41 | 26,892 | $2.4M | 21.8% |
| 4 | $91.54 | 19,000 | $1.7M | 15.6% |
| 5 | $91.54 | 19,000 | $1.7M | 15.6% |
| 6 | $92.50 | 2,900 |
| $268K |
| 2.4% |
| 7 | $93.57 | 1,208 | $113K | 1.0% |
| 8 | $93.57 | 1,208 | $113K | 1.0% |
| Total | $91.30 avg | 122,100 | $11.1M | 100% |
| Filing → |
| HZNP | SELL | 2022-05-20 | $2.3M | — | Filing → |
| HZNP | SELL | 2022-05-13 | $1.6M | — | Filing → |
| HZNP | SELL | 2022-05-10 | $672K | — | Filing → |